本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Redhill Biopharma Ltd

2.76
-0.0955-3.34%
盤後2.65-0.1145-4.14%17:47 EDT
成交量:4.42萬
成交額:12.17萬
市值:354.01萬
市盈率:-0.07
高:2.85
開:2.85
低:2.70
收:2.86
資料載入中...
2022/03/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/27

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/02

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/12

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/11

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses